Cancer stories that are directly relevant to your practice, or are just really interesting.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
Oncology Republic
Claim This Podcastby The Medical Republic
14 episodes
Updated Weekly
Accepts GuestsHas SponsorsLocation 🇬🇧
Podcast Overview
Cancer stories that are directly relevant to your practice, or are just really interesting.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
Language
🇺🇲
Publishing Since
3/21/2021
1 verified contact email on file for Oncology Republic
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
May 1, 2024
Comprehensive geriatric assessment in older cancer patients
<p>Comprehensive geriatric assessment aids clinical decision making and has numerous benefits for patients. But what is it, and how do you get started? </p><br><p>In this episode of <em>The Oncology Republic Podcast</em> we dig into the finer points of using comprehensive geriatric assessment in the management of older people with cancer. </p><br><p>Dr Paul Viray, a Melbourne-based consultant geriatrician and medical oncology registrar, feels there are misconceptions about what a comprehensive geriatric assessment is. He describes it more of a specific approach to medicine, rather than a specific tool or set of forms. </p><br><p>“The comprehensive geriatric assessment is the method of holistically going through all aspects of an older person’s life and finding out how to optimize each of those things, [such as] continence and cognition, how many medications they're taking, what their mobility is like, their falls risk, their nutritional status.” </p><br><p>Dr Michal Krasovitsky, a medical oncologist at the Kinghorn Cancer Center at St Vincent's Hospital in Darlinghurst, has worked closely with colleagues at the Cancer Institute NSW to make it easier for clinicians to access evidence-based screening tools that can be used in geriatric screening. He is pleasantly surprised by the results of their efforts. </p><br><p>“Registrars who I've been working with have all used the tool, and a number of my [other] colleagues have also used the tool. And even more impressively, in my mind, the non-medical oncology people I work with, including surgeons and radiation oncologists have also used the tool… and then using that as an opportunity for us to brainstorm what we’re going to do with that information [has been] extremely powerful.” </p><br><p>Dr Viray has been developing his own approach to comprehensive geriatric assessment, which he hopes will break down some of the barriers between different specialties. </p><br><p>“There’s this siloing of specialties, so geriatricians do this, cardiologists do that. Oncologists do this, radiation oncologists do that. If we work together, I think that would take away some of the angst oncologists [have], and [to build] another workforce to help our oncologists.” </p><br /><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
March 7, 2024
Older patients with cancer – experts chat about this important speciality crossover
<p>Older adults account for the majority of people living with and surviving cancer. What’s draws people to work in this space, and what issues do they deal with? </p><br><p>This episode of <em>The Oncology Republic Podcast</em> explores how the field of geriatric oncology has grown in Australia, and some of the challenges it faces. </p><br><p>Dr Paul Viray, a consultant geriatrician and medical oncology registrar who works across several sites in Victoria, says the geriatric oncology community in Australia has grown because of increased awareness about managing older patients in a more holistic fashion. </p><br><p>“If you spend a bit more time in the holistic care of the older adult, it’s so rewarding. And I think a lot of people want to do that more and more.” </p><br><p>Dr Michael Krasovitsky, chair of the Geriatric Oncology Multidisciplinary Service at St Vincent's Hospital in Darlinghurst, feels our nation’s “abysmal” funding model for geriatric oncology means we become reliant on having an engaged and inclusive community. </p><br><p>“Navigating the funding arrangements are extremely difficult, and ultimately to the detriment of patients. You need to come up with some sort of fake model of care that works in your specific hospital situation, which requires local champions often begging administrators to provide funding. </p><br><p>“We now have our <a href="https://www.cosa.org.au/about/projects/goeer-geriatric-oncology-emerging-experts-researchers/" rel="noopener noreferrer" target="_blank">geriatric oncology emerging experts and researchers group</a>, [which is] a really sizeable group of people who are engaged in researching and collaborating with overseas clinicians. That’s been really invaluable.” </p><br /><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
September 13, 2023
Rare cancers get a new, genomic pathway
<p>If Caitlin Delaney hadn’t pushed for genomic testing and off-label therapies, she might not have been around to share her insights on The Medical Podcast this week. </p><p>As a health professional she also had the benefit of health literacy and a personal assertiveness that may have well also helped her be at her daughter’s 10th birthday. </p><p>“There were lots of ‘sliding door’ moments. If I hadn't asked a certain question or pushed for a different answer or gotten a second or third opinion, then the outcome would be very different,” she says. </p><p>The epicentre of Ms Delaney’s survival is genetic testing. She says it’s critical because it opens the doorway to emerging new treatments, personalized medicine and clinical trials. </p><p>“These are critical for all cancer patients, but especially for rare cancer patients whose treatment options may be limited,” Ms Delaney said </p><p>Ms Delaney was diagnosed with stage 4 clear cell ovarian cancer nearly seven years ago. She is enthusiastic about PROSPECT a new cancer treatment pathway that provides genomic testing to Australians with rare or incurable cancers, and then provides access to any clinical trials and off-label therapies that might make a difference. </p><p>PROSPECT cancer screening program is a clever collaboration between University of New South Wales, NSW government and a whole range of players in the Australian medical research sector. </p><p>[ACAST LINK] </p><p> </p><p>Professor David Thomas leads Omico, the not-for-profit which runs PROSPECT’s cancer screening program. He is optimistic about PROSPECT bringing a bit more equity to cancer treatment for those with rare cancers who often miss out on trials or are and also for remote patients. </p><p>“Regional and rural Australia is very important to us and we're specifically trying to promote the program and work with our clinical colleagues in regional cancer centers. </p><p>“That specifically applies also to Aboriginal and Torres Strait Islander cancer patients. Rural and regional patients, as well as Indigenous cancer patients, have demonstrably worse outcomes. We don't want them to be left behind,” he says. </p><p>For the 150 people diagnosed each day with a rare cancer, it’s a new pathway that can make the difference and not just in the future. Professor Thomas says the program is not a philanthropic exercise with no connection with patient interests. </p><p>“The pace of research progress is so great that it's now creating options for patients in real time rather than for some future benefit. </p><p>“I would encourage us to think about research as just another part of the way of our armamentarium when we try to treat diseases like cancer,” he says. </p><br /><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
14 total episodes available
Deep-dive analytics for Oncology Republic
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Oncology Republic?
- How often does this podcast release new episodes?
This podcast updates weekly.
- Where can I listen to this podcast?
This podcast is available on 7 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.